Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts

PS2023-144-tn

Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts

Ayahuasca is a psychoactive tea brewed from the Amazonian plants, Banisteriopsis caapi with either Psychotria viridis or Diplopterys cabrerana, with recent trials demonstrating promise in treating depression, managing grief, and improving overall well-being. In the last three decades, ritual ayahuasca use has expanded to most urban centers throughout the world, with hundreds of participants estimated to be taking ayahuasca every night in the United States for addressing anxiety and depression. More information is needed regarding the therapeutic impact of naturalistic ayahuasca use on behavioral health outcomes.

Share: Assessing Syncretic Ayahuasca Practices Globally: Results from a multi-site cohort study of ayahuasca drinkers in non-tribal contexts

Facebook
Twitter
LinkedIn
Email

Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.